Current Landscape of Therapeutics for the Management of Hypertension - A Review
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Hypertension is a critical health problem. It is also the primary reason for coronary heart disease, stroke, and renal vascular disease. The use of herbal drugs in the management of any disease is increasing. They are considered the best immune booster to fight against several types of diseases. To date, the demand for herbal drugs has been increasing because of their excellent properties. This review highlights antihypertensive drugs, polyphenols, and synbiotics for managing hypertension. Evidence is mounting in favour of more aggressive blood pressure control with reduced adverse effects, especially for specific patient populations. This review aimed to present contemporary viewpoints and novel treatment options, including cutting-edge technological applications and emerging interventional and pharmaceutical therapies, as well as key concerns arising from several years of research and epidemiological observations related to the management of hypertension.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Current drug delivery - 21(2024), 5 vom: 23., Seite 662-682 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Fatima, Neda [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antihypertensive Agents |
---|
Anmerkungen: |
Date Completed 11.01.2024 Date Revised 11.01.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/1567201820666230623121433 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM358588855 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM358588855 | ||
003 | DE-627 | ||
005 | 20240114233729.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/1567201820666230623121433 |2 doi | |
028 | 5 | 2 | |a pubmed24n1256.xml |
035 | |a (DE-627)NLM358588855 | ||
035 | |a (NLM)37357524 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fatima, Neda |e verfasserin |4 aut | |
245 | 1 | 0 | |a Current Landscape of Therapeutics for the Management of Hypertension - A Review |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.01.2024 | ||
500 | |a Date Revised 11.01.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a Hypertension is a critical health problem. It is also the primary reason for coronary heart disease, stroke, and renal vascular disease. The use of herbal drugs in the management of any disease is increasing. They are considered the best immune booster to fight against several types of diseases. To date, the demand for herbal drugs has been increasing because of their excellent properties. This review highlights antihypertensive drugs, polyphenols, and synbiotics for managing hypertension. Evidence is mounting in favour of more aggressive blood pressure control with reduced adverse effects, especially for specific patient populations. This review aimed to present contemporary viewpoints and novel treatment options, including cutting-edge technological applications and emerging interventional and pharmaceutical therapies, as well as key concerns arising from several years of research and epidemiological observations related to the management of hypertension | ||
650 | 4 | |a Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Hypertension | |
650 | 4 | |a chronically high blood pressure. | |
650 | 4 | |a future aspects | |
650 | 4 | |a polyphenols | |
650 | 4 | |a synbiotics | |
650 | 4 | |a synthetic drugs | |
650 | 7 | |a Antihypertensive Agents |2 NLM | |
700 | 1 | |a Ashique, Sumel |e verfasserin |4 aut | |
700 | 1 | |a Upadhyay, Aakash |e verfasserin |4 aut | |
700 | 1 | |a Kumar, Shubneesh |e verfasserin |4 aut | |
700 | 1 | |a Kumar, Himanshu |e verfasserin |4 aut | |
700 | 1 | |a Kumar, Nitish |e verfasserin |4 aut | |
700 | 1 | |a Kumar, Prashant |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current drug delivery |d 2004 |g 21(2024), 5 vom: 23., Seite 662-682 |w (DE-627)NLM159100232 |x 1875-5704 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2024 |g number:5 |g day:23 |g pages:662-682 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/1567201820666230623121433 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2024 |e 5 |b 23 |h 662-682 |